References
- Fezza F, Bari M, Florio R, et al. Endocannabinoids, related compounds and their metabolic routes. Molecules. 2014;19:17078–17106.
- Rovito D, Giordano C, Vizza D, et al. Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells. J Cell Physiol. 2013;228:1314–1322.
- Rani Sagar D, Burston JJ, Woodhams SG, et al. Dynamic changes to the endocannabinoid system in models of chronic pain. Philos Trans R Soc Lond B Biol Sci. 2012;367:3300–3311.
- Pezzilli R. Pain in chronic pancreatitis: from the bench to the bedside. JOP. 2012;13:245–246.
- Pasricha PJ. Unraveling the mystery of pain in chronic pancreatitis. Nat Rev Gastroenterol Hepatol. 2012;9:140–151.
- Bockman DE, Büchler M, Beger HG. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology. 1994;107:219–230.
- Paice JA, Mulvey M, Bennett M, et al. AAPT diagnostic criteria for chronic cancer pain conditions. J Pain. 2017;18:233–246.
- Sarles H, Adler G, Dani R, et al. The pancreatitis classification of Marseilles-Rome 1988. Scand J Gastroenterol. 1989;24:641–642.
- Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology. 1999;116:1132–1140.
- Ottria R, Ravelli A, Gigli F, et al. Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices. J Chrom B. 2014; 958:83–89.
- Ottria R, Casati S, Ciuffreda P. Optimized synthesis and characterization of N-acylethanolamines and O-acylethanolamines, important family of lipid-signalling molecules. Chem Phys Lipids. 2012;165:705–711.
- Wewers ME, Lowe NK. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health. 1990;13:227–236.
- Pezzilli R, Billi P, Miniero R, et al. Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci. 1995;40:2341–2348.
- Corsi MM, Barassi A, Morselli-Labate AM, et al. Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severity. Pancreas. 2008;37:36–41.
- Pertwee RG, ed. Endocannabinoids, Handbook of Experimental Pharmacology. Switzerland: Springer International Publishing; 2015.
- Matsuda K, Mikami Y, Takeda K, et al. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. Tohoku J Exp Med. 2005;207:99–107.
- Michalski CW, Laukert T, Sauliunaite D, et al. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology. 2007;132:1968–1978.
- Gerich ME, Isfort RW, Brimhall B, et al. Medical marijuana for digestive disorders: high time to prescribe?. Am J Gastroenterol. 2015;110:208–214.
- Utomo WK, de Vries M, van Rijckevorsel DC, et al. Cannabinoid receptor agonist namisol does not affect cytokine levels in chronic pancreatitis patients. Am J Gastroenterol. 2015;110:1244–1245.
- Michalski CW, Maier M, Erkan M, et al. Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. PLoS One. 2008;3:e1701.
- Michalski CW, Oti FE, Erkan M, et al. Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer. 2008;122:742–750.
- Dando I, Donadelli M, Costanzo C, et al. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis. 2013;4:e664.
- Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014;5:5852–5872.
- Gullo L, Barbara L, Labò G. Effect of cessation of alcohol use on the course of pancreatic dysfunction in alcoholic pancreatitis. Gastroenterology. 1988;95:1063–1068.
- Talamini G, Bassi C, Falconi M, et al. Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications. Pancreas. 2007;35:320–326.
- Suchsland T, Aghdassi A, Kühn K, et al. Predictive factors for and incidence of hospital readmissions of patients with acute and chronic pancreatitis. Pancreatology. 2015;15:265–270.